<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of small bowel obstruction in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of small bowel obstruction in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Management of small bowel obstruction in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Liliana Bordeianou, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel Dante Yeh, MD, MHPE, FACS, FCCM, FASPEN</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Krishnan Raghavendran, MD, FACS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 03, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H372577745"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Small bowel obstruction (SBO) occurs when the normal flow of intestinal intraluminal contents is interrupted. The management of bowel obstruction depends upon the etiology, severity, and location of the obstruction. The goals of initial management are to relieve discomfort and restore normal fluid volume, acid-base balance, and electrolytes. Bowel compromise (ischemia, necrosis, or perforation) and a surgically correctable cause of SBO (eg, incarcerated hernia) require immediate surgical exploration; other patients may be candidates for a trial of nonoperative management. Although 60 to 85 percent of adhesion-related SBOs resolve without surgery, it is difficult to predict a priori which patients will fail nonoperative management. Non-adhesion-related SBO is usually secondary to another intra-abdominal process (eg, inflammation, infection), the targeted treatment of which will lead to the resolution of SBO symptoms.</p><p>This topic review will focus on the management of SBO. The clinical features and diagnosis of SBO are discussed separately. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults"</a>.)</p><p>Hypertonic water-soluble radiologic contrast (eg, Gastrografin) has been widely used therapeutically to treat adhesion-related SBO. Its use is mentioned here but discussed in depth in another topic. (See  <a class="medical medical_review" href="/d/html/115266.html" rel="external">"Gastrografin for adhesive small bowel obstruction"</a>.)</p><p class="headingAnchor" id="H372577752"><span class="h1">INITIAL MANAGEMENT</span><span class="headingEndMark"> — </span>Small bowel obstruction (SBO) is a common disease, accounting for 12 to 16 percent of surgical admissions and more than 300,000 operations annually in the United States [<a href="#rid1">1</a>]. Patients diagnosed with acute SBO should be admitted to the hospital and evaluated by a surgeon. </p><p class="headingAnchor" id="H2531219644"><span class="h2">Admission and surgical consultation</span><span class="headingEndMark"> — </span>Patients who present with acute SBO should be admitted to the hospital. Some studies have suggested that admission to a surgical service (versus medical service) is associated with improved clinical outcomes and decreased costs [<a href="#rid2">2-4</a>]. At a minimum, prompt surgical consultation should be obtained to determine if immediate surgical intervention is needed. (See <a class="local">'Indications for immediate surgery'</a> below.)</p><p>The use of standardized protocols has been shown to decrease time to surgical consultation and time to operative intervention (if needed) and shorten hospital length of stay (<a class="graphic graphic_algorithm graphicRef120954" href="/d/graphic/120954.html" rel="external">algorithm 1</a>) [<a href="#rid5">5</a>]. </p><p>Patients with chronic and/or intermittent SBO, such as that caused by Crohn's-related small bowel strictures or radiation enteritis, may be managed expectantly on an outpatient basis by limiting their oral intake to fluids. As long as hydration and normal electrolyte balance can be maintained (which may require outpatient fluid therapy), hospitalization may be avoided. Nevertheless, a structured plan is required to keep these patients engaged until their chronic SBO has resolved. </p><p class="headingAnchor" id="H372577759"><span class="h2">Fluid therapy</span><span class="headingEndMark"> — </span>Patients with bowel obstruction can have severe volume depletion, metabolic acidosis or alkalosis, and electrolyte abnormalities. This is particularly true for patients with copious emesis from proximal SBO, those with symptoms lasting several days prior to presentation, or obstruction that causes large-volume intraluminal fluid sequestration. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Pathophysiology'</a>.)</p><p>Upon admission, isotonic crystalloid such as <a class="drug drug_general" data-topicid="108196" href="/d/drug information/108196.html" rel="external">Lactated Ringer</a> solution or normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> may be appropriate for initial intravenous fluid therapy if the patient is dehydrated. Aggressive potassium repletion may be needed, but it is important to be certain the patient does not have acute kidney injury, in which case potassium supplementation should be given cautiously until renal function can be improved. (See  <a class="medical medical_review" href="/d/html/2296.html" rel="external">"Maintenance and replacement fluid therapy in adults"</a> and  <a class="medical medical_review" href="/d/html/14035.html" rel="external">"Overview of the management of acute kidney injury (AKI) in adults"</a>.) </p><p>Even for patients who require immediate surgery, fluid resuscitation, correction of acid-base balance and repletion of electrolytes can generally be completed prior to surgery, which helps minimize complications (eg, hypotension, arrhythmias) related to induction of anesthesia. (See  <a class="medical medical_review" href="/d/html/94135.html" rel="external">"Induction of general anesthesia: Overview", section on 'Selection of induction technique'</a>.)</p><p class="headingAnchor" id="H372577766"><span class="h2">Diet</span><span class="headingEndMark"> — </span>In general, most patients admitted for SBO should be made nil per os (NPO) to limit further bowel distension. However, a small subset of patients with partial bowel obstruction may tolerate a small amount of oral liquids. </p><p class="headingAnchor" id="H372577773"><span class="h2">Gastrointestinal decompression</span><span class="headingEndMark"> — </span>The need for gastrointestinal decompression in the setting of SBO may vary from patient to patient and remains a matter of clinical judgment. For patients with SBO that is associated with significant distension, nausea, and/or vomiting, we perform nasogastric tube decompression [<a href="#rid6">6-8</a>]. Such patients likely have complete or high-grade obstruction; decompression of the distended stomach improves patient comfort and also minimizes the passage of swallowed air, which can worsen distension [<a href="#rid9">9</a>]. The placement and management of nasogastric tubes is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/15070.html" rel="external">"Inpatient placement and management of nasogastric and nasoenteric tubes in adults"</a>.)</p><p>For patients with recurrent SBO who have undergone multiple prior operations, and in whom another operation is felt to be particularly risky, one can attempt long tube decompression as a component of conservative management to avoid further surgery. However, there are few data to support this practice over the use of standard nasogastric decompression. Older trials comparing standard nasogastric tubes and long tubes weighted with a mercury-filled balloon (eg, Miller-Abbott tube, Anderson tube, Dennis tube [<a href="#rid10">10,11</a>]) did not show a significant difference in the percentage of patients ultimately requiring surgical intervention [<a href="#rid7">7,12</a>]. However, a later randomized trial comparing 90 patients managed with an endoscopically placed long hydrophilic silicone tube with 96 patients managed with a nasogastric tube found a significantly decreased time to relief of clinical symptoms in the long tube group (4.1 versus 8.5 days) [<a href="#rid10">10</a>]. Overall effectiveness (ie, no need for surgery) was nearly doubled in the long tube group (90 versus 47 percent). The improved outcomes seen in this one study will need to be replicated in future studies before routine implementation; concerns remain over the potential risks of long tubes, such as knot formation. Overall, we do not advocate the routine use of long tubes in patients with SBO.</p><p class="headingAnchor" id="H3646142496"><span class="h2">Role of antibiotics</span><span class="headingEndMark"> — </span>For most patients with uncomplicated SBO, we suggest not administering prophylactic antibiotics. Although administering broad-spectrum antibiotics is practiced because of concerns for bacterial translocation, data are inadequate to support or refute such a practice [<a href="#rid13">13</a>].</p><p>However, antibiotics are warranted for patients with suspected bowel compromise (ie, ischemia, necrosis, or perforation), and standard perioperative prophylactic antibiotics should be administered to those who undergo operative exploration, depending upon the expected wound classification (<a class="graphic graphic_table graphicRef65369" href="/d/graphic/65369.html" rel="external">table 1</a>) [<a href="#rid14">14-16</a>]. (See  <a class="medical medical_review" href="/d/html/15075.html" rel="external">"Overview of gastrointestinal tract perforation", section on 'Antibiotics'</a>.)</p><p>Antibiotic therapy is also warranted to treat infectious causes of nonadhesive SBO (eg, infectious small bowel disease or colonic diverticulitis). Targeting the underlying causes in such patients is the key to the resolution of their bowel obstruction. (See <a class="local">'Nonadhesive small bowel obstruction'</a> below.)</p><p class="headingAnchor" id="H372577787"><span class="h1">INDICATIONS FOR IMMEDIATE SURGERY</span><span class="headingEndMark"> — </span>Immediate surgical exploration is indicated for either suspected bowel compromise (ie, perforation, necrosis, or ischemia) or treating a surgically correctable cause of small bowel obstruction (SBO), <strong>except</strong> adhesions.</p><p class="headingAnchor" id="H378591065"><span class="h2">Bowel compromise</span><span class="headingEndMark"> — </span>All patients suspected of having bowel compromise (ischemia, necrosis, or perforation) based upon clinical and radiologic examination should be taken to the operating room for abdominal exploration [<a href="#rid6">6,8</a>]. SBO with associated bowel compromise is sometimes referred to as complicated SBO.</p><p class="headingAnchor" id="H1074166347"><span class="h3">Clinical signs</span><span class="headingEndMark"> — </span>Clinical signs and symptoms that are associated with bowel ischemia include the following, but each of these clinical signs is nonspecific, cannot be used in isolation, and does not always indicate ischemia [<a href="#rid17">17-21</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Fever</p><p class="bulletIndent1"><span class="glyph">●</span>Leukocytosis</p><p class="bulletIndent1"><span class="glyph">●</span>Tachycardia that does not respond to fluid resuscitation</p><p class="bulletIndent1"><span class="glyph">●</span>Continuous or worsening abdominal pain, sometimes out of proportion to examination</p><p class="bulletIndent1"><span class="glyph">●</span>Metabolic and lactic acidosis</p><p class="bulletIndent1"><span class="glyph">●</span>Tachypnea</p><p class="bulletIndent1"><span class="glyph">●</span>Peritonitis</p><p class="bulletIndent1"><span class="glyph">●</span>Systemic inflammatory response syndrome (SIRS) </p><p></p><p>It is difficult to accurately predict bowel ischemia based upon clinical parameters alone [<a href="#rid22">22,23</a>]. In one study, experienced clinicians were wrong in their preoperative assessment more than half the time in patients eventually found to have gangrenous bowel [<a href="#rid23">23</a>]. </p><p class="headingAnchor" id="H3929291867"><span class="h3">Radiologic signs</span><span class="headingEndMark"> — </span>Abdominal computed tomography (CT) should be performed in all stable patients with suspected acute SBO since it is difficult to accurately predict bowel ischemia based on clinical parameters alone [<a href="#rid24">24</a>]. Oral and intravenous contrast can be helpful but are not always feasible depending on the clinical scenario (eg, acute kidney injury or complete obstruction). In addition to laboratory and clinical signs, the following radiologic signs will identify 70 to 96 percent of patients who will benefit from immediate surgery [<a href="#rid22">22,23,25-29</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Free air on plain radiographs or abdominal CT indicating bowel perforation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Signs of intestinal ischemia. Although advanced ischemia is usually obvious (eg, pneumatosis intestinalis, portal venous gas), it remains difficult to identify early and intermediate stages of bowel ischemia. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Exclude bowel compromise'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Closed-loop obstruction (eg, U-shaped, distended, fluid-filled loops; triangular loop; beak sign; two loops of collapsed bowel adjacent to the obstruction site) [<a href="#rid17">17,30</a>]. While true closed-loop obstructions are associated with bowel ischemia, they are often "overcalled" in radiology reports; clinical correlation is required. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Complete obstruction and closed-loop obstruction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other CT scan findings that are sometimes predictive of the need for surgery include findings of an abnormal course of a mesenteric vessel, a high-grade obstruction, a transition zone/point, a "whirl sign" [<a href="#rid31">31</a>], a "venous cut-off sign" [<a href="#rid32">32</a>], a "small bowel feces sign" [<a href="#rid26">26</a>], and high-density free peritoneal fluid [<a href="#rid33">33-35</a>]. However, these signs are also nonspecific. In one study that included 145 patients with high-grade obstruction on CT, 46 percent were successfully managed nonoperatively [<a href="#rid20">20</a>]. </p><p></p><p class="headingAnchor" id="H3631115973"><span class="h2">Surgical causes of small bowel obstruction</span><span class="headingEndMark"> — </span>By convention, timely surgery following adequate resuscitation is generally also offered to patients with SBO caused by one of the surgically correctable causes (eg, closed-loop obstruction, volvulus, intussusception, incarcerated hernia, gallstone ileus, foreign body ingestion, small bowel tumor). For these conditions, although surgical exploration does not need to be "immediate" as it is for bowel compromise, it should happen as soon as is practical, since the SBO is not likely to resolve without surgery.</p><p>Although adhesive SBO is also technically surgically correctable (by lysis of adhesion), data suggest that most patients resolve without surgery [<a href="#rid36">36</a>]. Thus, in the absence of suspected bowel compromise, adhesive SBO should be initially managed nonoperatively [<a href="#rid1">1,36,37</a>]. (See <a class="local">'Adhesive small bowel obstruction'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span>Closed-loop obstruction – Closed-loop obstruction can rapidly lead to bowel complications (ischemia, necrosis, perforation); thus, early identification and prompt surgical treatment are important to restore perfusion to the affected segment of bowel. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Complete obstruction and closed-loop obstruction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hernia – Among patients who present with SBO, acutely incarcerated hernias (abdominal or groin) cause the majority of complications [<a href="#rid38">38</a>]. Any acutely incarcerated hernia that is causing SBO but without signs of strangulation could undergo attempted manual reduction; a safe technique of manual reduction of an acute inguinal hernia, called GPS (Gentle, Prepared and Safe) Taxis approach, has been adopted by a group of surgeons [<a href="#rid39">39</a>]. Hernias that fail to reduce require immediate surgical repair [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1">By contrast, chronically incarcerated hernias are usually not the cause of an acute SBO, especially when they are associated with loss of domain (greater than 50 percent of viscera outside the abdominopelvic cavity). Thus, unless there are clinical or radiological signs mandating immediate surgical exploration, patients may undergo initial nonoperative management. Such patients should be followed closely by a surgeon, both for the acute SBO and for potential hernia repair following the resolution of the SBO. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Complicated hernia'</a>.)<strong> </strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Volvulus – SBO can be caused by small bowel (midgut) volvulus or cecal volvulus. Volvulus is technically a subset of closed-loop obstruction. Timely surgical correction is the only solution to avoid bowel loss and other complications. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Volvulus'</a> and  <a class="medical medical_review" href="/d/html/15163.html" rel="external">"Intestinal malrotation in adults"</a> and  <a class="medical medical_review" href="/d/html/1374.html" rel="external">"Cecal volvulus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intussusception – Intussusception is uncommon in adults but would require surgery if it causes SBO. Because intussusception is caused by a lead point or structural abnormality (eg, tumor) in up to 90 percent of adult cases [<a href="#rid41">41</a>], resection of the involved bowel segment is recommended over simple reduction [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Intussusception'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gallstone ileus or foreign body ingestion – The treatment for gallstone ileus is primarily surgical. All patients with gallstone ileus who are surgical candidates should undergo an enterolithotomy with the goal of relieving intestinal obstruction. (See  <a class="medical medical_review" href="/d/html/3683.html" rel="external">"Gallstone ileus"</a>.)</p><p></p><p class="bulletIndent1">Patients with a gallstone impacted in the duodenum (Bouveret syndrome) may benefit from a period of nonoperative management that will allow the stone to pass into the small bowel, where surgical retrieval is less likely to cause complications. Endoscopic fragmentation of stone can also be attempted in this location, with the goal of sparing the patient a duodenotomy should they need ultimate surgery [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Gallstones or foreign body'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Small bowel tumor – For patients who present with SBO due to a nonmetastatic or locally advanced primary small bowel tumor, operative intervention with curative intent should be pursued [<a href="#rid40">40</a>]. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Tumor'</a> and  <a class="medical medical_review" href="/d/html/2509.html" rel="external">"Treatment of small bowel neoplasms"</a>.)</p><p></p><p class="bulletIndent1">Bowel obstruction from incurable advanced malignant disease, commonly referred to as malignant bowel obstruction, is much more difficult to manage and is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/85393.html" rel="external">"Palliative care of bowel obstruction in cancer patients"</a>.)</p><p></p><p class="headingAnchor" id="H372577794"><span class="h1">NONOPERATIVE MANAGEMENT</span><span class="headingEndMark"> — </span>Most patients with small bowel obstruction (SBO) but no indication for immediate surgery can safely undergo an initial trial of nonoperative management [<a href="#rid44">44</a>]. Nonoperative management resolves symptoms in many patients with SBO, but success rates depend upon the etiology [<a href="#rid7">7,45,46</a>]. </p><p>It is pertinent to distinguish adhesive from nonadhesive SBO as the components of nonoperative management may differ between the two. Adhesive SBO is caused by intra-abdominal adhesions most commonly brought on by prior abdominal surgeries or previous episodes of abdominal inflammation (eg, pelvic inflammatory disease). Because adhesions cannot be directly seen on any imaging modalities, adhesive SBO is usually a diagnosis of exclusion made by combining a known history of prior abdominal surgery with a lack of other discernable causes of SBO on imaging studies [<a href="#rid36">36</a>]. By contrast, nonadhesive SBO is typically diagnosed by imaging studies (eg, the presence of inflammation or abscess). In industrialized nations, adhesive SBO is more prevalent than nonadhesive SBO [<a href="#rid47">47</a>]. </p><p class="headingAnchor" id="H585124909"><span class="h2">Adhesive small bowel obstruction</span><span class="headingEndMark"> — </span>In the setting of adhesive SBO, nonoperative management is overall successful in 65 to 83 percent of patients [<a href="#rid48">48-52</a>]. However, nonoperative management of adhesive SBO is associated with higher recurrence rates and lower disease-free intervals compared with operative management [<a href="#rid53">53-55</a>]. </p><p class="headingAnchor" id="H372577843"><span class="h3">Water-soluble contrast</span><span class="headingEndMark"> — </span>For patients with adhesive SBO, hypertonic water-soluble gastrointestinal contrast agents (eg, Gastrografin) may be therapeutic [<a href="#rid8">8,56-62</a>]. Gastrografin draws fluid into the lumen of the bowel due to its hypertonicity, decreasing intestinal wall edema and stimulating intestinal peristalsis. Evidence from randomized trials suggests that a Gastrografin challenge can predict clinical resolution of SBO without surgery, reduce the length of hospital stay, and accelerate the resolution of SBO in patients who would have resolved without surgery, but it does <strong>not</strong> reduce the need for surgical intervention [<a href="#rid56">56,57,61,63-65</a>]. (See  <a class="medical medical_review" href="/d/html/115266.html" rel="external">"Gastrografin for adhesive small bowel obstruction"</a>.)</p><p>Therapeutic use of water-soluble contrast is contraindicated in the presence of bowel compromise (ischemia, necrosis, or perforation) and has only been studied in patients with adhesive SBO. Therefore, Gastrografin challenge should not be administered to patients with a known nonadhesive cause of SBO (see <a class="local">'Nonadhesive small bowel obstruction'</a> below). Additionally, Gastrografin has not been found to be effective for treating postoperative SBO, and the agent is contraindicated during pregnancy. (See <a class="local">'Special cases'</a> below.)</p><p>Unless contraindicated, we suggest giving a challenge of hypertonic water-soluble contrast agent (eg, Gastrografin) as part of the nonoperative treatment of adhesive SBO (<a class="graphic graphic_algorithm graphicRef120954" href="/d/graphic/120954.html" rel="external">algorithm 1</a>). In order to maximize the benefit, Gastrografin should be administered as soon as possible once nasogastric decompression is performed. Implementation of an evidence-based SBO pathway incorporating Gastrografin is associated with reduced length of stay without any difference in rates of readmission, surgery, or need for bowel resection (in those requiring surgery) [<a href="#rid66">66</a>].</p><p>In most clinical situations, an abdominal computed tomography (CT) scan has been performed and a nasogastric tube has been inserted once the diagnosis of SBO is made. The stomach should be aspirated to dryness before Gastrografin is administered via the nasogastric tube. Although practices may vary [<a href="#rid44">44,67</a>], 100 mL of <strong>undiluted</strong> Gastrografin is most often given as a one-time dose [<a href="#rid63">63</a>], and the nasogastric tube is clamped for the next two to four hours. If a nasogastric tube is not placed, the same volume of Gastrografin can be administered orally [<a href="#rid44">44</a>]. It is essential that the nursing staff understands the purpose of using undiluted Gastrografin in this setting as it is far more common in nursing practice that Gastrografin is diluted in water before use as an oral contrast agent for CT. Reasonable precautions are also required to prevent aspiration as Gastrografin can cause pneumonitis when aspirated. </p><p>After Gastrografin is administered, a plain abdominal radiograph (ie, Kidney-Ureter-Bladder [KUB]) should be obtained in 6 to 24 hours. Within that window of time, the radiograph can be taken at a time that is convenient for both the patient and surgical team caring for them. Evidence of Gastrografin reaching the colon is highly predictive of the resolution of SBO without surgical intervention [<a href="#rid68">68-70</a>] and should inform the clinical decision to advance the patient's diet (<a class="graphic graphic_algorithm graphicRef120954" href="/d/graphic/120954.html" rel="external">algorithm 1</a>). Failure of the contrast to reach the colon 24 hours later should influence, but not dictate, the decision to operate. A significant percentage of patients may require longer duration of nonoperative management for successful SBO resolution [<a href="#rid71">71</a>]. The time allowed for nonoperative resolution following instillation of Gastrografin is a matter of clinical judgment in these patients. (See <a class="local">'Duration of observation'</a> below.) </p><p class="headingAnchor" id="H2424066067"><span class="h3">Serial monitoring</span><span class="headingEndMark"> — </span>Although the incidence of bowel ischemia during nonoperative management of SBO is low at 3 to 6 percent [<a href="#rid17">17</a>], and the incidence of complications with adhesive obstruction is low overall [<a href="#rid23">23,72-81</a>], the patient still needs to be carefully monitored with serial abdominal examination and laboratory studies; some will benefit from follow-up imaging. Frequent clinical reassessments of the patient are necessary to ensure that complications are not developing. </p><p class="headingAnchor" id="H3211586528"><span class="h4">Clinical assessment</span><span class="headingEndMark"> — </span>Patients should be regularly assessed clinically with one of three possible outcomes: </p><p class="bulletIndent1"><span class="glyph">●</span>Resolution of SBO is generally accompanied by a decrease in abdominal distension, the passage of flatus and/or stool per rectum, and a decrease in the volume of nasogastric tube output. In cases where the obstruction has clearly resolved, the nasogastric tube can be removed and diet initiated and advanced as tolerated. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The patient remains stable but signs and symptoms of SBO persist. For such patients, surgery may eventually be required. The optimal duration of nonoperative management is debated, but most surgeons would wait for up to three to five days before operating. In this setting, operating too soon may submit patients to an unnecessary operation, while waiting too long to operate is associated with increased complication rates and hospital length of stay. A three- to five-day trial of nonoperative management is a reasonable compromise that has been endorsed by multiple authorities. (See <a class="local">'Duration of observation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who deteriorate should undergo immediate surgical exploration. Clinical deterioration (eg, fever, tachycardia, increasing pain or distension, acidosis, leukocytosis) is usually caused by bowel compromise, for which urgent surgical attention is required. (See <a class="local">'Failure of nonoperative management'</a> below.)</p><p></p><p>The volume of output from the nasogastric tube should be carefully documented to help with clinical judgments regarding the progression or resolution of the obstruction and the requirement for intravenous fluid therapy. Nasogastric losses can be replaced with normal <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> plus <a class="drug drug_general" data-topicid="9795" href="/d/drug information/9795.html" rel="external">potassium chloride</a> (30 to 40 mEq/L). (See  <a class="medical medical_review" href="/d/html/2296.html" rel="external">"Maintenance and replacement fluid therapy in adults"</a>.)</p><p class="headingAnchor" id="H1854449053"><span class="h4">Laboratory studies</span><span class="headingEndMark"> — </span>Laboratory tests should be repeated only as indicated by clinical parameters. As examples, in patients with severe electrolyte or acid-base disturbances, particularly those with renal dysfunction, blood chemistries should be repeated to ensure that replacement therapy is effective. Repeat assay of white blood cell counts may be helpful if there is concern for bowel ischemia and/or strangulation. </p><p>Serum procalcitonin (PCT), which is a marker of inflammation, is a promising prognostic biomarker for predicting failure of nonoperative management of SBO [<a href="#rid8">8,82,83</a>]. In the Acute Bowel Obstruction Diagnostic (ABOD) study, for example, PCT levels were significantly higher in the surgery group compared with the nonoperatively managed group (0.53 versus 0.14 ng/mL) and significantly higher in those managed surgically who had ischemia compared with those who did not (1.16 versus 0.21 ng/mL) [<a href="#rid82">82</a>]. However, additional prospective studies are required to validate the use of PCT for routine clinical use. </p><p class="headingAnchor" id="H1109315275"><span class="h4">Follow-up imaging</span><span class="headingEndMark"> — </span>Aside from abdominal plain radiographs performed as a part of the water-soluble contrast challenge, we do not recommend routine serial imaging studies without clinical indication. </p><p>Although abdominal plain radiographs may be useful for assessing whether or not the patient has clearly resolved their obstruction by demonstrating that gas or oral contrast has passed from the small bowel into the colon, they are otherwise insensitive for all but the most advanced stages of bowel obstruction (eg, free air indicating perforation). Therefore, we do not recommend routine serial abdominal radiographs for SBO.</p><p>If the patient deteriorates or fails to improve after an adequate trial of nonoperative management for adhesive SBO (typically three to five days, depending on clinical situation), patients may undergo a repeat abdominal CT [<a href="#rid59">59,84</a>]. However, many surgeons would perform surgical exploration on clinical grounds at this point without further imaging (<a class="graphic graphic_algorithm graphicRef120954" href="/d/graphic/120954.html" rel="external">algorithm 1</a>). (See <a class="local">'Failure of nonoperative management'</a> below.)</p><p class="headingAnchor" id="H372577857"><span class="h3">Failure of nonoperative management</span><span class="headingEndMark"> — </span>Approximately a quarter of patients admitted for SBO will eventually require surgery [<a href="#rid55">55</a>]. </p><p>The decision to proceed with surgical exploration or continue nonoperative management is based primarily on the clinical status of the patient. Clinical deterioration or developing a complicated obstruction during a trial of nonoperative management should lead to prompt surgical exploration [<a href="#rid8">8</a>]. In the absence of clinical deterioration, failure to regain bowel function after three to five days of nonoperative management may also suggest the need for an operation. Several studies have reported that delay in operation intervention greater than three [<a href="#rid85">85</a>] to five days [<a href="#rid86">86,87</a>] was associated with higher morbidity [<a href="#rid88">88</a>], higher mortality, and longer hospital stay [<a href="#rid86">86</a>]. </p><p>However, stable patients with known "frozen" abdomens, recent abdominal surgery, presence of enterocutaneous fistula, or other complicating factors may be observed for a longer period of time with possible institution of <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a>. Clinical judgment of the surgeon is required to weigh the benefit and harm of surgical exploration against further observation. (See <a class="local">'Special cases'</a> below.)</p><p class="headingAnchor" id="H588590065"><span class="h4">Duration of observation</span><span class="headingEndMark"> — </span>In contemporary practice, it is widely accepted that stable patients with SBO may undergo initial nonoperative management as long as there is no complication (eg, bowel ischemia, necrosis, or perforation) or deterioration. The point of contention, however, is how long one can wait before surgical exploration becomes mandatory. The challenge to clinicians is that earlier operations may be unnecessary, whereas delayed operation may be associated with worse patient outcomes [<a href="#rid89">89</a>].</p><p>The World Society of Emergency Surgery (Bologna) guidelines (2017) recommended waiting for up to three days before surgical exploration [<a href="#rid7">7,90</a>]. The Eastern Association for the Surgery of Trauma (EAST) guidelines (2012) recommended waiting for up to five days before surgical exploration [<a href="#rid6">6,8</a>]. We suggest that in the absence of clinical deterioration, most patients with adhesive SBO should undergo surgery after up to three to five days of unsuccessful nonoperative management, depending on the clinical situation (<a class="graphic graphic_algorithm graphicRef120954" href="/d/graphic/120954.html" rel="external">algorithm 1</a>). </p><p>Earlier or later surgery may be warranted in certain patient populations, although disease distribution and location need to be carefully considered and the decision to operate or not individualized accordingly. As an example, early postoperative SBO can be managed nonoperatively for a longer period of time (eg, up to six weeks) in the absence of clinical deterioration. (See <a class="local">'Special cases'</a> below and  <a class="medical medical_review" href="/d/html/85393.html" rel="external">"Palliative care of bowel obstruction in cancer patients", section on 'Surgical candidates'</a>.)</p><p>With nonoperative management, appropriately selected patients usually improve within two to five days [<a href="#rid17">17,51</a>]. However, it should be noted that for patients who ultimately require an operation, a delay of more than one day has been identified as a risk factor for requiring bowel resection [<a href="#rid91">91</a>]. In other studies, nonoperative management for uncomplicated adhesive bowel obstruction exceeding three to five days was associated with increased morbidity and mortality [<a href="#rid85">85,86</a>]. </p><p class="headingAnchor" id="H1977721991"><span class="h4">Predicting requirement for surgery</span><span class="headingEndMark"> — </span>For surgeons, the "holy grail" of SBO management is to predict who will and will not fail nonoperative management. Logic stands that operating on the former early improves patient outcomes, reduces complications, and saves resources. However, it proves quite difficult to prospectively identify the patients who are destined for surgery with accuracy.</p><p>In a multivariate analysis, six clinical and radiographic values correlated with the need for bowel resection [<a href="#rid92">92</a>]. A scoring system was developed that assigned one point to each of these variables, which are listed below. Among 233 consecutive patients with bowel obstruction, 11 patients with a total score ≥4 points required bowel resection. A total score ≥3 points predicted the need for resection with a specificity of 90.8 percent. The variables include:</p><p class="bulletIndent1"><span class="glyph">●</span>History of pain lasting greater than four days</p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal guarding on physical examination</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated C-reactive protein (CRP) above 75 mg/L </p><p class="bulletIndent1"><span class="glyph">●</span>Elevated white blood cell (WBC) count above 10 </p><p class="bulletIndent1"><span class="glyph">●</span>Presence of &gt;500 mL of free intra-abdominal fluid on CT </p><p class="bulletIndent1"><span class="glyph">●</span>Reduced wall contrast enhancement on CT  </p><p></p><p>Another group of investigators identified the presence of free fluid and high-grade obstruction on CT scan as strong predictors for early surgery [<a href="#rid93">93</a>].</p><p>Abnormal initial laboratory values in sodium, creatinine, and hematocrit are not predictive of the need for operative intervention [<a href="#rid91">91</a>]. </p><p class="headingAnchor" id="H3899835798"><span class="h2">Nonadhesive small bowel obstruction</span><span class="headingEndMark"> — </span>A trial of nonoperative management is warranted in patients with one of the following etiologies for their bowel obstruction who do not otherwise have indications for surgical exploration (see <a class="local">'Indications for immediate surgery'</a> above). Because the SBO in these patients is not caused by adhesions, a Gastrografin challenge is not indicated, as the efficacy and safety of the therapeutic use of Gastrografin has only been demonstrated in adhesive SBO. Instead, targeted therapy for the underlying cause (eg, antibiotics for infection), if available, is paramount to the resolution of SBO in these patients.</p><p class="headingAnchor" id="H1028226236"><span class="h3">Inflammatory bowel disease</span><span class="headingEndMark"> — </span>Patients who do not have fulminant disease causing complete bowel obstruction may respond to medical therapy. The medical management of inflammatory bowel disease is discussed in other topics. (See  <a class="medical medical_review" href="/d/html/4069.html" rel="external">"Overview of the medical management of mild (low risk) Crohn disease in adults"</a> and  <a class="medical medical_review" href="/d/html/4051.html" rel="external">"Medical management of low-risk adult patients with mild to moderate ulcerative colitis"</a>.)</p><p>However, refractory strictures due to repeated episodes of inflammation usually require eventual resection and/or stricturoplasty to relieve obstruction. (See  <a class="medical medical_review" href="/d/html/86198.html" rel="external">"Surgical management of Crohn disease"</a>.)</p><p class="headingAnchor" id="H1856313309"><span class="h3">Infectious small bowel disease</span><span class="headingEndMark"> — </span>Patients who present with a partial SBO due to tuberculosis may improve with medical management, although, similar to Crohn disease, delayed diagnosis is more likely to require surgery [<a href="#rid94">94</a>]. (See  <a class="medical medical_review" href="/d/html/1238.html" rel="external">"Abdominal tuberculosis"</a>.)</p><p>In some countries, parasites can also cause SBO, which should be treated with anthelminthic therapy. (See  <a class="medical medical_review" href="/d/html/5673.html" rel="external">"Ascariasis"</a>.)</p><p class="headingAnchor" id="H3264704101"><span class="h3">Colonic diverticular disease causing small bowel obstruction</span><span class="headingEndMark"> — </span>Here, the small bowel is obstructed secondarily by the pelvic inflammation or abscess caused by acute colonic diverticulitis. Antibiotic therapy reduces peridiverticular inflammation and may relieve obstructive symptoms. (See  <a class="medical medical_review" href="/d/html/1380.html" rel="external">"Acute colonic diverticulitis: Medical management"</a>.)</p><p class="headingAnchor" id="H1693030083"><span class="h3">Radiation enteritis</span><span class="headingEndMark"> — </span>Small bowel damage (radiation enteritis) can be caused by radiation therapy for cancer of the cervix, endometrium, ovary, bladder, or prostate. It results in an obliterative arteritis that leads to intestinal ischemia or stricture, followed by SBO. Partial SBO is the most common clinical manifestation. Because of a higher risk of anastomotic leak, surgical intervention for SBO due to radiation enteritis is best avoided [<a href="#rid95">95</a>]. When an operation is absolutely necessary, an intestinal bypass is preferred to resection [<a href="#rid96">96</a>]. Specific approaches to radiation enteritis are discussed separately. (See  <a class="medical medical_review" href="/d/html/15165.html" rel="external">"Surgical approach to radiation enteritis"</a>.)</p><p class="headingAnchor" id="H2077620265"><span class="h3">Malignant obstruction</span><span class="headingEndMark"> — </span>Primary or secondary tumor involvement can lead to SBO due to intrinsic or extrinsic compression; in addition, bowel obstruction may be due to adhesions or postradiation fibrosis. Tumors can also impair bowel motility by infiltrating the mesentery, nerves (eg, celiac plexus), or bowel wall. Some cancers (eg, colonic, ovarian, pancreatic, and gastric) have a particular propensity for peritoneal dissemination [<a href="#rid97">97</a>]. </p><p>Although some surgeons may be reluctant to operate on patients with a history of prior surgery for intra-abdominal malignancy because they believe that obstruction due to metastatic cancer is not likely to be relieved by surgery, this is not necessarily the case, as many are due to adhesions. Radiological evaluations with CT scans can potentially differentiate peritoneal carcinomatosis from adhesive small bowel obstruction. Nonoperative therapy for malignant obstruction is associated with a high failure rate and high mortality, but on the other hand, palliative surgery for those in whom the obstruction cannot be relieved is also associated with overall poor outcomes [<a href="#rid98">98-102</a>]. </p><p>There is no consensus regarding the optimal treatment strategy for management of malignant bowel obstruction and no strong evidence addressing the relative value of palliative surgery versus medical management, or for supporting the efficacy of any specific treatment for improving quality of life or prolonging survival. A decision to proceed to surgical intervention requires careful weighing of risks and benefits, including an assessment of the estimated life expectancy and goals of care (<a class="graphic graphic_algorithm graphicRef95084" href="/d/graphic/95084.html" rel="external">algorithm 2</a>). </p><p>Management strategies for SBO in patients with intra-abdominal malignancy are discussed in a separate dedicated topic. (See  <a class="medical medical_review" href="/d/html/85393.html" rel="external">"Palliative care of bowel obstruction in cancer patients"</a>.)</p><p class="headingAnchor" id="H746390421"><span class="h1">SPECIAL CASES</span></p><p class="headingAnchor" id="H905270955"><span class="h2">Complete bowel obstruction</span><span class="headingEndMark"> — </span>The management of patients with complete small bowel obstruction (SBO) due to adhesions is controversial. Although complete adhesive SBO is associated with a higher failure rate of nonoperative management and a higher requirement for small bowel resection (31 percent) in some series [<a href="#rid103">103</a>], others have demonstrated that nonoperative management is still successful in 41 to 73 percent of patients [<a href="#rid48">48,53</a>]. Thus, patients with a complete bowel obstruction can be treated nonoperatively unless there is an indication for immediate surgery. (See <a class="local">'Indications for immediate surgery'</a> above.)</p><p class="headingAnchor" id="H2595662631"><span class="h2">Postoperative bowel obstruction</span><span class="headingEndMark"> — </span>SBO that occurs within four to six weeks of an abdominal surgery is called postoperative SBO. Adhesions associated with early postoperative bowel obstruction rarely lead to strangulation. Meanwhile, after 10 to 14 days postoperatively, adhesions are dense and hypervascular, making reoperation difficult. Consequently, postoperative SBO should not only be treated nonoperatively but also for a duration longer than non-postoperative SBO, in the absence of clinical deterioration. Some have suggested withholding repeat surgery until after six weeks, when adhesions mature, so it would be safer to operate [<a href="#rid40">40</a>]. </p><p>In a retrospective study of postoperative SBO, 91 percent of 34 patients who were treated with home <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> recovered bowel function without an operation after a median of 60 days (range 17 to 244 days) [<a href="#rid104">104</a>]. By contrast, early reoperation in 27 patients at a mean of 17 days after the index operation was complicated by 12 bowel resections, 5 incidental enterotomies, 3 new stomas, 2 enterocutaneous fistulas, 1 anastomotic leak, and 1 fascial dehiscence. </p><p>Although Gastrografin challenge has been tried and is safe for postoperative SBO, it has not produced any positive effect [<a href="#rid105">105,106</a>]. Therefore, it should be not administered to postoperative patients with SBO. (See  <a class="medical medical_review" href="/d/html/15155.html" rel="external">"Measures to prevent prolonged postoperative ileus", section on 'Other pharmacologic treatments'</a>.)</p><p class="headingAnchor" id="H2765107015"><span class="h2">Patients without prior abdominal surgery</span><span class="headingEndMark"> — </span>Although adhesions are most commonly formed as a response to prior abdominal surgery, they can develop in the absence of prior surgery. One prospective clinical study reported that 10 percent of first-time laparotomies had adhesions [<a href="#rid107">107</a>]. A study of 752 consecutive autopsies reported adhesions in 28 percent of those who had never undergone laparotomy [<a href="#rid108">108</a>]. In several single-center observational studies, 5 to 16 percent of SBO occurred in patients who had no prior surgery, radiotherapy, or known peritoneal inflammatory disease [<a href="#rid109">109</a>].</p><p>Although SBO is most often caused by acquired adhesions from previous abdominal surgery, it can also be caused by congenital or inflammatory adhesions. In five series, 100, 76, 62, 35, 30, and 26 percent of patients operated for SBO in patients without prior abdominal surgery were found to have adhesion as the etiology; the average was 48 percent [<a href="#rid110">110-115</a>]. </p><p>Alternatively, SBO can also be caused by a mechanical etiology such as a tumor. In several series, 3 [<a href="#rid116">116</a>] to 13 percent of SBOs were caused by a malignancy in the small bowel, mesentery, or retroperitoneum [<a href="#rid111">111-113,116</a>]. Abdominal computed tomography (CT) imaging can help elucidate the exact etiology of the obstruction. (See  <a class="medical medical_review" href="/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults", section on 'Abdominal CT'</a>.)</p><p>In the absence of another indication for immediate surgery, patients with SBO but no prior abdominal surgery can still be managed nonoperatively, including therapeutic Gastrografin challenge [<a href="#rid115">115,117</a>], but there is a greater chance that the SBO will not resolve without surgery [<a href="#rid110">110,111</a>]. If surgery is required, laparoscopic exploration is ideal in this patient population [<a href="#rid90">90</a>]. </p><p>In a systematic review and meta-analysis of six studies with SBO in the absence of prior abdominopelvic surgery, more than half of the patients underwent a trial of nonoperative management, which often failed [<a href="#rid118">118</a>]. The most common etiology was de novo adhesion (54 percent), whereas malignancy was found in 7.7 to 13.4 percent of patients, most not suspected before surgery. However, if nonoperative management is successful, the prognosis is good. One study reported that of 63 SBOs in patients lacking prior abdominal surgery who were successfully managed with nonoperative management, 58 (92 percent) did not experience a recurrence during a mean 4.5 years of follow-up [<a href="#rid110">110</a>].</p><p class="headingAnchor" id="H3985171141"><span class="h2">Older adults</span><span class="headingEndMark"> — </span>Older adult patients often present late in the course of their illness and report atypical or nonspecific symptoms [<a href="#rid119">119,120</a>]; therefore, abdominal CT is important for a correct diagnosis. Although emergency surgery in older adults can cause significant morbidity and mortality, delaying necessary surgery may lead to negative consequences as well. In one retrospective study, the mortality in older patients undergoing delayed surgery was much higher than older patients undergoing early surgery (14 versus 3 percent) [<a href="#rid120">120</a>]. Thus, experts advocate early operative intervention for management of SBO in older adults if they do not resolve quickly with nonoperative management [<a href="#rid40">40,121</a>]. </p><p class="headingAnchor" id="H217940063"><span class="h2">Pregnancy</span><span class="headingEndMark"> — </span>SBO in pregnant women is rare; one-half of reported cases are due to adhesions and the other half due to nonadhesive causes (eg, internal hernia, volvulus). Magnetic resonance imaging (MRI) should be used in lieu of CT for the initial diagnosis. Indications for immediate surgery are the same as for nonpregnant patients. Patients with adhesive SBO may undergo a trial of nonoperative management with a low threshold for operation. Due to a lack of safety data of the contrast agent, Gastrografin challenge should not be administered to pregnant patients [<a href="#rid122">122</a>]. (See  <a class="medical medical_review" href="/d/html/4807.html" rel="external">"Approach to acute abdominal/pelvic pain in pregnant and postpartum patients", section on 'Bowel obstruction'</a>.)</p><p class="headingAnchor" id="H1519201293"><span class="h2">Bariatric patients</span><span class="headingEndMark"> — </span>Patients may be susceptible to developing SBO after certain bariatric procedures (eg, Roux-en-Y gastric bypass) because of a variety of reasons, including adhesions, internal hernias, intussusception, and closed loop obstruction due to mesenteric defects [<a href="#rid123">123</a>]. In one large series of &gt;800 consecutive cases of laparoscopic Roux-en-Y gastric bypass, internal hernia was the most common etiology and was frequently missed on CT scan [<a href="#rid124">124</a>]. Once SBO is suspected, early operative intervention is recommended for bariatric patients. Contrary to recommendations for nonbariatric patients, early postoperative SBO should undergo prompt surgical exploration to avoid anastomotic leak or bowel ischemia [<a href="#rid125">125</a>]. The type of surgical intervention depends on operative findings and may require lysis of adhesions, reduction of internal hernia, and repair of abdominal wall defect or mesenteric defect. Depending on surgeon expertise, surgery can be performed open or laparoscopically. (See  <a class="medical medical_review" href="/d/html/140689.html" rel="external">"Bariatric operations: Late complications with acute presentations", section on 'Small bowel obstruction'</a>.)</p><p class="headingAnchor" id="H3014242398"><span class="h1">OUTCOMES</span></p><p class="headingAnchor" id="H3179212759"><span class="h2">Mortality and morbidity</span><span class="headingEndMark"> — </span>In a retrospective National Inpatient Sample database study of close to two million patients diagnosed with adhesive small bowel obstruction (SBO) between 2003 and 2013, the rate of operative intervention declined from 46 to 42 percent, while the delay between admission and operative intervention shortened from 5.29 to 3.77 days [<a href="#rid126">126</a>]. Meanwhile, the in-hospital mortality rate decreased from 5 to 4 percent (or by 6 percent per year), and the hospital length of stay decreased from 10 to 9 days. </p><p class="headingAnchor" id="H3767866979"><span class="h2">Recurrence</span><span class="headingEndMark"> — </span>In a longitudinal, propensity-matched, administrative database study of nearly 28,000 patients with adhesive SBO, those who underwent operative intervention (22 percent) had a lower risk of recurrence (13 versus 21 percent) [<a href="#rid55">55</a>]. The five-year probability of recurrence increased with each episode of SBO until surgical intervention, at which point the risk of subsequent recurrence decreased by approximately half.</p><p>In another administrative database study, among the nearly 16,000 patients with adhesive SBO who were managed nonoperatively during the index admission, 19 percent were readmitted, and 35 percent of those readmitted required an operation [<a href="#rid127">127</a>]. Operations during the first readmission conferred a greater risk of death (5 versus 1 percent) than no operation but a longer time to a second readmission among the survivors. </p><p class="headingAnchor" id="H2791691076"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/116755.html" rel="external">"Society guideline links: Bowel obstruction"</a>.)</p><p class="headingAnchor" id="H372577864"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/16718.html" rel="external">"Patient education: Small bowel obstruction (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H372577871"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Small bowel obstruction (SBO) occurs when the normal flow of intestinal contents is interrupted. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial management</strong> – Patients diagnosed with acute SBO should be admitted to the hospital and evaluated by a surgeon. The initial management includes volume resuscitation, correction of metabolic abnormalities, bowel rest, and gastrointestinal decompression (with a nasogastric tube) for those with significant abdominal distension, nausea, or vomiting (<a class="graphic graphic_algorithm graphicRef120954" href="/d/graphic/120954.html" rel="external">algorithm 1</a>). (See <a class="local">'Initial management'</a> above.)</p><p></p><p class="bulletIndent1">For most patients with uncomplicated SBO, we suggest not administering prophylactic antibiotics (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). However, we administer standard perioperative prophylactic antibiotics to patients with suspected bowel compromise (ie, ischemia, necrosis, or perforation) undergoing operative exploration, depending upon the expected wound classification. (See <a class="local">'Role of antibiotics'</a> above and  <a class="medical medical_review" href="/d/html/15075.html" rel="external">"Overview of gastrointestinal tract perforation", section on 'Antibiotics'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitive management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Indications for immediate surgery</strong> – Patients with clinical (fever, persistent tachycardia, focal or generalized peritonitis) or radiologic signs of bowel compromise (ischemia, necrosis, perforation) require immediate surgical exploration. By convention, timely surgery is generally also offered to patients with SBO caused by one of the surgically correctable causes, except adhesions. (See <a class="local">'Indications for immediate surgery'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Patients without an indication for immediate surgery</strong> – These patients are managed nonoperatively with serial abdominal examinations and laboratory and/or imaging studies as indicated by clinical parameters. In industrialized nations, adhesive SBO is more prevalent than nonadhesive SBO. In the setting of adhesive SBO, nonoperative management is overall successful in 65 to 80 percent of patients. (See <a class="local">'Nonoperative management'</a> above.)</p><p></p><p class="bulletIndent2">For patients with adhesive SBO, we suggest giving a hypertonic water-soluble contrast agent (eg, Gastrografin) as a part of nonoperative treatment (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Limited data suggest that a Gastrografin challenge can accelerate the resolution of SBO and reduce the length of hospital stay. However, there is also evidence to suggest that it does <strong>not</strong> reduce the need for future surgical intervention. Therapeutic use of Gastrografin has not been studied for nonadhesive SBO, is not effective against postoperative SBO, and may not be safe for pregnant patients. (See <a class="local">'Water-soluble contrast'</a> above and  <a class="medical medical_review" href="/d/html/115266.html" rel="external">"Gastrografin for adhesive small bowel obstruction"</a>.) </p><p></p><p class="bulletIndent2">The optimal duration of nonoperative management is uncertain and largely depends on the patient's clinical status and situation. For most clinically stable patients with SBO, we suggest that nonoperative management <strong>not</strong> be extended beyond three to five days given the increased morbidity and mortality associated with this approach (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). However, there are some clinical scenarios in which prolonging nonoperative management may be appropriate. As an example, those with early postoperative SBO can be managed for a longer period of time (eg, up to six weeks) in the absence of clinical deterioration. (See <a class="local">'Duration of observation'</a> above and <a class="local">'Special cases'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonadhesive SBO</strong> – SBO can also be caused by nonadhesive etiologies (eg, inflammatory bowel disease, infection, radiation, malignancy), against which targeted therapies are paramount for the resolution of the bowel obstruction. (See <a class="local">'Nonadhesive small bowel obstruction'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Maung AA, Johnson DC, Piper GL, et al. Evaluation and management of small-bowel obstruction: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg 2012; 73:S362.</a></li><li><a class="nounderline abstract_t">Malangoni MA, Times ML, Kozik D, Merlino JI. Admitting service influences the outcomes of patients with small bowel obstruction. Surgery 2001; 130:706.</a></li><li><a class="nounderline abstract_t">Schwab DP, Blackhurst DW, Sticca RP. Operative acute small bowel obstruction: admitting service impacts outcome. Am Surg 2001; 67:1034.</a></li><li><a class="nounderline abstract_t">Aquina CT, Becerra AZ, Probst CP, et al. Patients With Adhesive Small Bowel Obstruction Should Be Primarily Managed by a Surgical Team. Ann Surg 2016; 264:437.</a></li><li><a class="nounderline abstract_t">Wahl WL, Wong SL, Sonnenday CJ, et al. Implementation of a small bowel obstruction guideline improves hospital efficiency. Surgery 2012; 152:626.</a></li><li><a class="nounderline abstract_t">Oyasiji T, Angelo S, Kyriakides TC, Helton SW. Small bowel obstruction: outcome and cost implications of admitting service. Am Surg 2010; 76:687.</a></li><li><a class="nounderline abstract_t">Brolin RE, Krasna MJ, Mast BA. Use of tubes and radiographs in the management of small bowel obstruction. Ann Surg 1987; 206:126.</a></li><li><a class="nounderline abstract_t">Diaz JJ Jr, Bokhari F, Mowery NT, et al. Guidelines for management of small bowel obstruction. J Trauma 2008; 64:1651.</a></li><li><a class="nounderline abstract_t">Dorsey ST, Harrington ET, Iv WF, Emerman CL. Ileus and small bowel obstruction in an emergency department observation unit: are there outcome predictors? West J Emerg Med 2011; 12:404.</a></li><li><a class="nounderline abstract_t">Chen XL, Ji F, Lin Q, et al. A prospective randomized trial of transnasal ileus tube vs nasogastric tube for adhesive small bowel obstruction. World J Gastroenterol 2012; 18:1968.</a></li><li><a class="nounderline abstract_t">Gowen GF. Long tube decompression is successful in 90% of patients with adhesive small bowel obstruction. Am J Surg 2003; 185:512.</a></li><li><a class="nounderline abstract_t">Fleshner PR, Siegman MG, Slater GI, et al. A prospective, randomized trial of short versus long tubes in adhesive small-bowel obstruction. Am J Surg 1995; 170:366.</a></li><li><a class="nounderline abstract_t">Sagar PM, MacFie J, Sedman P, et al. Intestinal obstruction promotes gut translocation of bacteria. Dis Colon Rectum 1995; 38:640.</a></li><li><a class="nounderline abstract_t">Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg 2017; 152:784.</a></li><li><a class="nounderline abstract_t">Khan S, Gupta DK, Khan DN. Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis. Kathmandu Univ Med J (KUMJ) 2005; 3:55.</a></li><li><a class="nounderline abstract_t">Gonzenbach HR, Simmen HP, Amgwerd R. Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections. Ann Surg 1987; 205:271.</a></li><li><a class="nounderline abstract_t">Fevang BT, Jensen D, Svanes K, Viste A. Early operation or conservative management of patients with small bowel obstruction? Eur J Surg 2002; 168:475.</a></li><li><a class="nounderline abstract_t">Takeuchi K, Tsuzuki Y, Ando T, et al. Clinical studies of strangulating small bowel obstruction. Am Surg 2004; 70:40.</a></li><li><a class="nounderline abstract_t">Tsumura H, Ichikawa T, Hiyama E, et al. Systemic inflammatory response syndrome (SIRS) as a predictor of strangulated small bowel obstruction. Hepatogastroenterology 2004; 51:1393.</a></li><li><a class="nounderline abstract_t">Rocha FG, Theman TA, Matros E, et al. Nonoperative management of patients with a diagnosis of high-grade small bowel obstruction by computed tomography. Arch Surg 2009; 144:1000.</a></li><li><a class="nounderline abstract_t">Eltarawy IG, Etman YM, Zenati M, et al. Acute mesenteric ischemia: the importance of early surgical consultation. Am Surg 2009; 75:212.</a></li><li><a class="nounderline abstract_t">SILEN W, HEIN MF, GOLDMAN L. Strangulation obstruction of the small intestine. Arch Surg 1962; 85:121.</a></li><li><a class="nounderline abstract_t">Sarr MG, Bulkley GB, Zuidema GD. Preoperative recognition of intestinal strangulation obstruction. Prospective evaluation of diagnostic capability. Am J Surg 1983; 145:176.</a></li><li><a class="nounderline abstract_t">Ros PR, Huprich JE. ACR Appropriateness Criteria on suspected small-bowel obstruction. J Am Coll Radiol 2006; 3:838.</a></li><li><a class="nounderline abstract_t">Zielinski MD, Eiken PW, Heller SF, et al. Prospective, observational validation of a multivariate small-bowel obstruction model to predict the need for operative intervention. J Am Coll Surg 2011; 212:1068.</a></li><li><a class="nounderline abstract_t">Zielinski MD, Eiken PW, Bannon MP, et al. Small bowel obstruction-who needs an operation? A multivariate prediction model. World J Surg 2010; 34:910.</a></li><li><a class="nounderline abstract_t">Kim JH, Ha HK, Kim JK, et al. Usefulness of known computed tomography and clinical criteria for diagnosing strangulation in small-bowel obstruction: analysis of true and false interpretation groups in computed tomography. World J Surg 2004; 28:63.</a></li><li><a class="nounderline abstract_t">Mallo RD, Salem L, Lalani T, Flum DR. Computed tomography diagnosis of ischemia and complete obstruction in small bowel obstruction: a systematic review. J Gastrointest Surg 2005; 9:690.</a></li><li><a class="nounderline abstract_t">Obuz F, Terzi C, Sökmen S, et al. The efficacy of helical CT in the diagnosis of small bowel obstruction. Eur J Radiol 2003; 48:299.</a></li><li><a class="nounderline abstract_t">Balthazar EJ, Birnbaum BA, Megibow AJ, et al. Closed-loop and strangulating intestinal obstruction: CT signs. Radiology 1992; 185:769.</a></li><li><a class="nounderline abstract_t">Duda JB, Bhatt S, Dogra VS. Utility of CT whirl sign in guiding management of small-bowel obstruction. AJR Am J Roentgenol 2008; 191:743.</a></li><li><a class="nounderline abstract_t">Ho YC. "Venous cut-off sign" as an adjunct to the "whirl sign" in recognizing acute small bowel volvulus via CT scan. J Gastrointest Surg 2012; 16:2005.</a></li><li><a class="nounderline abstract_t">Hwang JY, Lee JK, Lee JE, Baek SY. Value of multidetector CT in decision making regarding surgery in patients with small-bowel obstruction due to adhesion. Eur Radiol 2009; 19:2425.</a></li><li><a class="nounderline abstract_t">O'Daly BJ, Ridgway PF, Keenan N, et al. Detected peritoneal fluid in small bowel obstruction is associated with the need for surgical intervention. Can J Surg 2009; 52:201.</a></li><li><a class="nounderline abstract_t">Matsushima K, Inaba K, Dollbaum R, et al. High-Density Free Fluid on Computed Tomography: a Predictor of Surgical Intervention in Patients with Adhesive Small Bowel Obstruction. J Gastrointest Surg 2016; 20:1861.</a></li><li><a class="nounderline abstract_t">Ten Broek RPG, Krielen P, Di Saverio S, et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg 2018; 13:24.</a></li><li><a class="nounderline abstract_t">Azagury D, Liu RC, Morgan A, Spain DA. Small bowel obstruction: A practical step-by-step evidence-based approach to evaluation, decision making, and management. J Trauma Acute Care Surg 2015; 79:661.</a></li><li><a class="nounderline abstract_t">Markogiannakis H, Messaris E, Dardamanis D, et al. Acute mechanical bowel obstruction: clinical presentation, etiology, management and outcome. World J Gastroenterol 2007; 13:432.</a></li><li><a class="nounderline abstract_t">Pawlak M, East B, de Beaux AC. Algorithm for management of an incarcerated inguinal hernia in the emergency settings with manual reduction. Taxis, the technique and its safety. Hernia 2021; 25:1253.</a></li><li><a class="nounderline abstract_t">Bower KL, Lollar DI, Williams SL, et al. Small Bowel Obstruction. Surg Clin North Am 2018; 98:945.</a></li><li><a class="nounderline abstract_t">Honjo H, Mike M, Kusanagi H, Kano N. Adult intussusception: a retrospective review. World J Surg 2015; 39:134.</a></li><li><a class="nounderline abstract_t">Yakan S, Caliskan C, Makay O, et al. Intussusception in adults: clinical characteristics, diagnosis and operative strategies. World J Gastroenterol 2009; 15:1985.</a></li><li><a class="nounderline abstract_t">Zhao JC, Barrera E, Salabat M, et al. Endoscopic treatment for Bouveret syndrome. Surg Endosc 2013; 27:655.</a></li><li><a class="nounderline abstract_t">Di Saverio S, Coccolini F, Galati M, et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2013 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg 2013; 8:42.</a></li><li><a class="nounderline abstract_t">Kendrick ML. Partial small bowel obstruction: clinical issues and recent technical advances. Abdom Imaging 2009; 34:329.</a></li><li><a class="nounderline abstract_t">Foster NM, McGory ML, Zingmond DS, Ko CY. Small bowel obstruction: a population-based appraisal. J Am Coll Surg 2006; 203:170.</a></li><li><a class="nounderline abstract_t">ten Broek RP, Issa Y, van Santbrink EJ, et al. Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis. BMJ 2013; 347:f5588.</a></li><li><a class="nounderline abstract_t">Seror D, Feigin E, Szold A, et al. How conservatively can postoperative small bowel obstruction be treated? Am J Surg 1993; 165:121.</a></li><li><a class="nounderline abstract_t">Tanaka S, Yamamoto T, Kubota D, et al. Predictive factors for surgical indication in adhesive small bowel obstruction. Am J Surg 2008; 196:23.</a></li><li><a class="nounderline abstract_t">Jeong WK, Lim SB, Choi HS, Jeong SY. Conservative management of adhesive small bowel obstructions in patients previously operated on for primary colorectal cancer. J Gastrointest Surg 2008; 12:926.</a></li><li><a class="nounderline abstract_t">Cox MR, Gunn IF, Eastman MC, et al. The safety and duration of non-operative treatment for adhesive small bowel obstruction. Aust N Z J Surg 1993; 63:367.</a></li><li><a class="nounderline abstract_t">Diaz A, Ricci KB, Rushing AP, et al. Re-examining "Never Letting the Sun Rise or Set on a Bowel Obstruction" in the Era of Acute Care Surgery. J Gastrointest Surg 2021; 25:512.</a></li><li><a class="nounderline abstract_t">Fevang BT, Fevang J, Lie SA, et al. Long-term prognosis after operation for adhesive small bowel obstruction. Ann Surg 2004; 240:193.</a></li><li><a class="nounderline abstract_t">Williams SB, Greenspon J, Young HA, Orkin BA. Small bowel obstruction: conservative vs. surgical management. Dis Colon Rectum 2005; 48:1140.</a></li><li><a class="nounderline abstract_t">Behman R, Nathens AB, Mason S, et al. Association of Surgical Intervention for Adhesive Small-Bowel Obstruction With the Risk of Recurrence. JAMA Surg 2019; 154:413.</a></li><li><a class="nounderline abstract_t">Di Saverio S, Catena F, Ansaloni L, et al. Water-soluble contrast medium (gastrografin) value in adhesive small intestine obstruction (ASIO): a prospective, randomized, controlled, clinical trial. World J Surg 2008; 32:2293.</a></li><li><a class="nounderline abstract_t">Kumar P, Kaman L, Singh G, Singh R. Therapeutic role of oral water soluble iodinated contrast agent in postoperative small bowel obstruction. Singapore Med J 2009; 50:360.</a></li><li><a class="nounderline abstract_t">Assalia A, Schein M, Kopelman D, et al. Therapeutic effect of oral Gastrografin in adhesive, partial small-bowel obstruction: a prospective randomized trial. Surgery 1994; 115:433.</a></li><li><a class="nounderline abstract_t">Choi HK, Law WL, Ho JW, Chu KW. Value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective evaluation. World J Gastroenterol 2005; 11:3742.</a></li><li><a class="nounderline abstract_t">Choi HK, Chu KW, Law WL. Therapeutic value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomized trial. Ann Surg 2002; 236:1.</a></li><li><a class="nounderline abstract_t">Burge J, Abbas SM, Roadley G, et al. Randomized controlled trial of Gastrografin in adhesive small bowel obstruction. ANZ J Surg 2005; 75:672.</a></li><li><a class="nounderline abstract_t">Yagci G, Kaymakcioglu N, Can MF, et al. Comparison of Urografin versus standard therapy in postoperative small bowel obstruction. J Invest Surg 2005; 18:315.</a></li><li><a class="nounderline abstract_t">Abbas S, Bissett IP, Parry BR. Oral water soluble contrast for the management of adhesive small bowel obstruction. Cochrane Database Syst Rev 2007; :CD004651.</a></li><li><a class="nounderline abstract_t">Branco BC, Barmparas G, Schnüriger B, et al. Systematic review and meta-analysis of the diagnostic and therapeutic role of water-soluble contrast agent in adhesive small bowel obstruction. Br J Surg 2010; 97:470.</a></li><li><a class="nounderline abstract_t">Farid M, Fikry A, El Nakeeb A, et al. Clinical impacts of oral gastrografin follow-through in adhesive small bowel obstruction (SBO). J Surg Res 2010; 162:170.</a></li><li><a class="nounderline abstract_t">Lyu HG, Castillo-Angeles M, Bruno M, et al. Outcomes of a low-osmolar water-soluble contrast pathway in small bowel obstruction. J Trauma Acute Care Surg 2019; 87:630.</a></li><li><a class="nounderline abstract_t">Abbas SM, Bissett IP, Parry BR. Meta-analysis of oral water-soluble contrast agent in the management of adhesive small bowel obstruction. Br J Surg 2007; 94:404.</a></li><li><a class="nounderline abstract_t">Ceresoli M, Coccolini F, Catena F, et al. Water-soluble contrast agent in adhesive small bowel obstruction: a systematic review and meta-analysis of diagnostic and therapeutic value. Am J Surg 2016; 211:1114.</a></li><li><a class="nounderline abstract_t">Atahan K, Aladağli I, Cökmez A, et al. Hyperosmolar water-soluble contrast medium in the management of adhesive small-intestine obstruction. J Int Med Res 2010; 38:2126.</a></li><li><a class="nounderline abstract_t">Chen SC, Lin FY, Lee PH, et al. Water-soluble contrast study predicts the need for early surgery in adhesive small bowel obstruction. Br J Surg 1998; 85:1692.</a></li><li><a class="nounderline abstract_t">Mulder MB, Hernandez M, Ray-Zack MD, et al. A Significant Proportion of Small Bowel Obstructions Require &gt;48 Hours to Resolve After Gastrografin. J Surg Res 2019; 233:408.</a></li><li><a class="nounderline abstract_t">Bizer LS, Liebling RW, Delany HM, Gliedman ML. Small bowel obstruction: the role of nonoperative treatment in simple intestinal obstruction and predictive criteria for strangulation obstruction. Surgery 1981; 89:407.</a></li><li><a class="nounderline abstract_t">McEntee G, Pender D, Mulvin D, et al. Current spectrum of intestinal obstruction. Br J Surg 1987; 74:976.</a></li><li><a class="nounderline abstract_t">Mucha P Jr. Small intestinal obstruction. Surg Clin North Am 1987; 67:597.</a></li><li><a class="nounderline abstract_t">Chiedozi LC, Aboh IO, Piserchia NE. Mechanical bowel obstruction. Review of 316 cases in Benin City. Am J Surg 1980; 139:389.</a></li><li><a class="nounderline abstract_t">Wysocki A, Krzywoń J. [Causes of intestinal obstruction]. Przegl Lek 2001; 58:507.</a></li><li><a class="nounderline abstract_t">Akçakaya A, Alimoğlu O, Hevenk T, et al. [Mechanical intestinal obstruction caused by abdominal wall hernias]. Ulus Travma Derg 2000; 6:260.</a></li><li><a class="nounderline abstract_t">Kössi J, Salminen P, Laato M. The epidemiology and treatment patterns of postoperative adhesion induced intestinal obstruction in Varsinais-Suomi Hospital District. Scand J Surg 2004; 93:68.</a></li><li><a class="nounderline abstract_t">Kuremu RT, Jumbi G. Adhesive intestinal obstruction. East Afr Med J 2006; 83:333.</a></li><li><a class="nounderline abstract_t">Roscher R, Frank R, Baumann A, Beger HG. [Results of surgical treatment of mechanical ileus of the small intestine]. Chirurg 1991; 62:614.</a></li><li><a class="nounderline abstract_t">Cox MR, Gunn IF, Eastman MC, et al. The operative aetiology and types of adhesions causing small bowel obstruction. Aust N Z J Surg 1993; 63:848.</a></li><li><a class="nounderline abstract_t">Cosse C, Regimbeau JM, Fuks D, et al. Serum procalcitonin for predicting the failure of conservative management and the need for bowel resection in patients with small bowel obstruction. J Am Coll Surg 2013; 216:997.</a></li><li><a class="nounderline abstract_t">Markogiannakis H, Memos N, Messaris E, et al. Predictive value of procalcitonin for bowel ischemia and necrosis in bowel obstruction. Surgery 2011; 149:394.</a></li><li><a class="nounderline abstract_t">Onoue S, Katoh T, Shibata Y, et al. The value of contrast radiology for postoperative adhesive small bowel obstruction. Hepatogastroenterology 2002; 49:1576.</a></li><li><a class="nounderline abstract_t">Keenan JE, Turley RS, McCoy CC, et al. Trials of nonoperative management exceeding 3 days are associated with increased morbidity in patients undergoing surgery for uncomplicated adhesive small bowel obstruction. J Trauma Acute Care Surg 2014; 76:1367.</a></li><li><a class="nounderline abstract_t">Schraufnagel D, Rajaee S, Millham FH. How many sunsets? Timing of surgery in adhesive small bowel obstruction: a study of the Nationwide Inpatient Sample. J Trauma Acute Care Surg 2013; 74:181.</a></li><li><a class="nounderline abstract_t">Kothari AN, Liles JL, Holmes CJ, et al. "Right place at the right time" impacts outcomes for acute intestinal obstruction. Surgery 2015; 158:1116.</a></li><li><a class="nounderline abstract_t">Chiu AS, Jean RA, Davis KA, Pei KY. Impact of Race on the Surgical Management of Adhesive Small Bowel Obstruction. J Am Coll Surg 2018; 226:968.</a></li><li><a class="nounderline abstract_t">Fung BSC, Behman R, Nguyen MA, et al. Longer Trials of Non-operative Management for Adhesive Small Bowel Obstruction Are Associated with Increased Complications. J Gastrointest Surg 2020; 24:890.</a></li><li><a class="nounderline abstract_t">Catena F, Di Saverio S, Kelly MD, et al. Bologna Guidelines for Diagnosis and Management of Adhesive Small Bowel Obstruction (ASBO): 2010 Evidence-Based Guidelines of the World Society of Emergency Surgery. World J Emerg Surg 2011; 6:5.</a></li><li><a class="nounderline abstract_t">Leung AM, Vu H. Factors predicting need for and delay in surgery in small bowel obstruction. Am Surg 2012; 78:403.</a></li><li><a class="nounderline abstract_t">Schwenter F, Poletti PA, Platon A, et al. Clinicoradiological score for predicting the risk of strangulated small bowel obstruction. Br J Surg 2010; 97:1119.</a></li><li><a class="nounderline abstract_t">Kulvatunyou N, Pandit V, Moutamn S, et al. A multi-institution prospective observational study of small bowel obstruction: Clinical and computerized tomography predictors of which patients may require early surgery. J Trauma Acute Care Surg 2015; 79:393.</a></li><li><a class="nounderline abstract_t">Chalya PL, McHembe MD, Mshana SE, et al. Tuberculous bowel obstruction at a university teaching hospital in Northwestern Tanzania: a surgical experience with 118 cases. World J Emerg Surg 2013; 8:12.</a></li><li><a class="nounderline abstract_t">Galland RB, Spencer J. Surgical management of radiation enteritis. Surgery 1986; 99:133.</a></li><li><a class="nounderline abstract_t">Lillemoe KD, Brigham RA, Harmon JW, et al. Surgical management of small-bowel radiation enteritis. Arch Surg 1983; 118:905.</a></li><li><a class="nounderline abstract_t">Chen JH, Huang TC, Chang PY, et al. Malignant bowel obstruction: A retrospective clinical analysis. Mol Clin Oncol 2014; 2:13.</a></li><li><a class="nounderline abstract_t">Paul Olson TJ, Pinkerton C, Brasel KJ, Schwarze ML. Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. JAMA Surg 2014; 149:383.</a></li><li><a class="nounderline abstract_t">Richards WO, Williams LF Jr. Obstruction of the large and small intestine. Surg Clin North Am 1988; 68:355.</a></li><li><a class="nounderline abstract_t">Butler JA, Cameron BL, Morrow M, et al. Small bowel obstruction in patients with a prior history of cancer. Am J Surg 1991; 162:624.</a></li><li><a class="nounderline abstract_t">Gallick HL, Weaver DW, Sachs RJ, Bouwman DL. Intestinal obstruction in cancer patients. An assessment of risk factors and outcome. Am Surg 1986; 52:434.</a></li><li><a class="nounderline abstract_t">Ripamonti C, De Conno F, Ventafridda V, et al. Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol 1993; 4:15.</a></li><li><a class="nounderline abstract_t">Nauta RJ. Advanced abdominal imaging is not required to exclude strangulation if complete small bowel obstructions undergo prompt laparotomy. J Am Coll Surg 2005; 200:904.</a></li><li><a class="nounderline abstract_t">Burneikis D, Stocchi L, Steiger E, et al. Parenteral Nutrition Instead of Early Reoperation in the Management of Early Postoperative Small Bowel Obstruction. J Gastrointest Surg 2020; 24:109.</a></li><li><a class="nounderline abstract_t">Biondo S, Miquel J, Espin-Basany E, et al. A Double-Blinded Randomized Clinical Study on the Therapeutic Effect of Gastrografin in Prolonged Postoperative Ileus After Elective Colorectal Surgery. World J Surg 2016; 40:206.</a></li><li><a class="nounderline abstract_t">Vather R, Josephson R, Jaung R, et al. Gastrografin in Prolonged Postoperative Ileus: A Double-blinded Randomized Controlled Trial. Ann Surg 2015; 262:23.</a></li><li><a class="nounderline abstract_t">Menzies D, Ellis H. Intestinal obstruction from adhesions--how big is the problem? Ann R Coll Surg Engl 1990; 72:60.</a></li><li><a class="nounderline abstract_t">Weibel MA, Majno G. Peritoneal adhesions and their relation to abdominal surgery. A postmortem study. Am J Surg 1973; 126:345.</a></li><li><a class="nounderline abstract_t">Amara Y, Leppaniemi A, Catena F, et al. Diagnosis and management of small bowel obstruction in virgin abdomen: a WSES position paper. World J Emerg Surg 2021; 16:36.</a></li><li><a class="nounderline abstract_t">Tavangari FR, Batech M, Collins JC, Tejirian T. Small Bowel Obstructions in a Virgin Abdomen: Is an Operation Mandatory? Am Surg 2016; 82:1038.</a></li><li><a class="nounderline abstract_t">Beardsley C, Furtado R, Mosse C, et al. Small bowel obstruction in the virgin abdomen: the need for a mandatory laparotomy explored. Am J Surg 2014; 208:243.</a></li><li><a class="nounderline abstract_t">Ng YY, Ngu JC, Wong AS. Small bowel obstruction in the virgin abdomen: time to challenge surgical dogma with evidence. ANZ J Surg 2018; 88:91.</a></li><li><a class="nounderline abstract_t">Strajina V, Kim BD, Zielinski MD. Small bowel obstruction in a virgin abdomen. Am J Surg 2019; 218:521.</a></li><li><a class="nounderline abstract_t">Skoglar A, Gunnarsson U, Falk P. Band adhesions not related to previous abdominal surgery - A retrospective cohort analysis of risk factors. Ann Med Surg (Lond) 2018; 36:185.</a></li><li><a class="nounderline abstract_t">Fukami Y, Kaneoka Y, Maeda A, et al. Clinical Effect of Water-Soluble Contrast Agents for Small Bowel Obstruction in the Virgin Abdomen. World J Surg 2018; 42:88.</a></li><li><a class="nounderline abstract_t">Butt MU, Velmahos GC, Zacharias N, et al. Adhesional small bowel obstruction in the absence of previous operations: management and outcomes. World J Surg 2009; 33:2368.</a></li><li><a class="nounderline abstract_t">Collom ML, Duane TM, Campbell-Furtick M, et al. Deconstructing dogma: Nonoperative management of small bowel obstruction in the virgin abdomen. J Trauma Acute Care Surg 2018; 85:33.</a></li><li><a class="nounderline abstract_t">Choi J, Fisher AT, Mulaney B, et al. Safety of Foregoing Operation for Small Bowel Obstruction in the Virgin Abdomen: Systematic Review and Meta-Analysis. J Am Coll Surg 2020; 231:368.</a></li><li><a class="nounderline abstract_t">Laurell H, Hansson LE, Gunnarsson U. Acute abdominal pain among elderly patients. Gerontology 2006; 52:339.</a></li><li><a class="nounderline abstract_t">Springer JE, Bailey JG, Davis PJ, Johnson PM. Management and outcomes of small bowel obstruction in older adult patients: a prospective cohort study. Can J Surg 2014; 57:379.</a></li><li><a class="nounderline abstract_t">Ozturk E, van Iersel M, Stommel MM, et al. Small bowel obstruction in the elderly: a plea for comprehensive acute geriatric care. World J Emerg Surg 2018; 13:48.</a></li><li><a class="nounderline abstract_t">Condello V, Zdanowicz U, Di Matteo B, et al. Allograft tendons are a safe and effective option for revision ACL reconstruction: a clinical review. Knee Surg Sports Traumatol Arthrosc 2019; 27:1771.</a></li><li><a class="nounderline abstract_t">Elms L, Moon RC, Varnadore S, et al. Causes of small bowel obstruction after Roux-en-Y gastric bypass: a review of 2,395 cases at a single institution. Surg Endosc 2014; 28:1624.</a></li><li><a class="nounderline abstract_t">Gunabushanam G, Shankar S, Czerniach DR, et al. Small-bowel obstruction after laparoscopic Roux-en-Y gastric bypass surgery. J Comput Assist Tomogr 2009; 33:369.</a></li><li><a class="nounderline abstract_t">Shimizu H, Maia M, Kroh M, et al. Surgical management of early small bowel obstruction after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2013; 9:718.</a></li><li><a class="nounderline abstract_t">Matsushima K, Sabour A, Park C, et al. Management of adhesive small bowel obstruction: A distinct paradigm shift in the United States. J Trauma Acute Care Surg 2019; 86:383.</a></li><li><a class="nounderline abstract_t">Wessels LE, Calvo RY, Dunne CE, et al. Outcomes in Adhesive Small Bowel Obstruction from a Large Statewide Database: What to Expect after Non-Operative Management. J Trauma Acute Care Surg 2019.</a></li></ol></div><div id="topicVersionRevision">Topic 89300 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23114494" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Evaluation and management of small-bowel obstruction: an Eastern Association for the Surgery of Trauma practice management guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11602902" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Admitting service influences the outcomes of patients with small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11730219" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Operative acute small bowel obstruction: admitting service impacts outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27433901" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Patients With Adhesive Small Bowel Obstruction Should Be Primarily Managed by a Surgical Team.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22939746" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Implementation of a small bowel obstruction guideline improves hospital efficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20698371" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Small bowel obstruction: outcome and cost implications of admitting service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3606237" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Use of tubes and radiographs in the management of small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18545135" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Guidelines for management of small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22224128" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Ileus and small bowel obstruction in an emergency department observation unit: are there outcome predictors?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22563179" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : A prospective randomized trial of transnasal ileus tube vs nasogastric tube for adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12781876" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Long tube decompression is successful in 90% of patients with adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7573730" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : A prospective, randomized trial of short versus long tubes in adhesive small-bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7774478" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Intestinal obstruction promotes gut translocation of bacteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28467526" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16401946" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3548611" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Imipenem (N-F-thienamycin) versus netilmicin plus clindamycin. A controlled and randomized comparison in intra-abdominal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12549688" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Early operation or conservative management of patients with small bowel obstruction?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14964545" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical studies of strangulating small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15362761" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Systemic inflammatory response syndrome (SIRS) as a predictor of strangulated small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19917935" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Nonoperative management of patients with a diagnosis of high-grade small bowel obstruction by computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19350855" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Acute mesenteric ischemia: the importance of early surgical consultation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13912825" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Strangulation obstruction of the small intestine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6849489" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Preoperative recognition of intestinal strangulation obstruction. Prospective evaluation of diagnostic capability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17412182" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : ACR Appropriateness Criteria on suspected small-bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21458305" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Prospective, observational validation of a multivariate small-bowel obstruction model to predict the need for operative intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20217412" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Small bowel obstruction-who needs an operation? A multivariate prediction model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14648046" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Usefulness of known computed tomography and clinical criteria for diagnosing strangulation in small-bowel obstruction: analysis of true and false interpretation groups in computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15862265" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Computed tomography diagnosis of ischemia and complete obstruction in small bowel obstruction: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14652150" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The efficacy of helical CT in the diagnosis of small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1438761" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Closed-loop and strangulating intestinal obstruction: CT signs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18716103" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Utility of CT whirl sign in guiding management of small-bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22580843" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : "Venous cut-off sign" as an adjunct to the "whirl sign" in recognizing acute small bowel volvulus via CT scan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19415288" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Value of multidetector CT in decision making regarding surgery in patients with small-bowel obstruction due to adhesion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19503664" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Detected peritoneal fluid in small bowel obstruction is associated with the need for surgical intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27613731" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : High-Density Free Fluid on Computed Tomography: a Predictor of Surgical Intervention in Patients with Adhesive Small Bowel Obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29946347" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26402543" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Small bowel obstruction: A practical step-by-step evidence-based approach to evaluation, decision making, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17230614" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Acute mechanical bowel obstruction: clinical presentation, etiology, management and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34036484" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Algorithm for management of an incarcerated inguinal hernia in the emergency settings with manual reduction. Taxis, the technique and its safety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30243455" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Small Bowel Obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25192846" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Adult intussusception: a retrospective review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19399931" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Intussusception in adults: clinical characteristics, diagnosis and operative strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23052513" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Endoscopic treatment for Bouveret syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24112637" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2013 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18597140" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Partial small bowel obstruction: clinical issues and recent technical advances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16864029" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Small bowel obstruction: a population-based appraisal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24092941" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8418687" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : How conservatively can postoperative small bowel obstruction be treated?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18367141" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Predictive factors for surgical indication in adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18060466" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Conservative management of adhesive small bowel obstructions in patients previously operated on for primary colorectal cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8481137" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The safety and duration of non-operative treatment for adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32043222" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Re-examining "Never Letting the Sun Rise or Set on a Bowel Obstruction" in the Era of Acute Care Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15273540" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Long-term prognosis after operation for adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15906139" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Small bowel obstruction: conservative vs. surgical management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30698610" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Association of Surgical Intervention for Adhesive Small-Bowel Obstruction With the Risk of Recurrence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18688562" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Water-soluble contrast medium (gastrografin) value in adhesive small intestine obstruction (ASIO): a prospective, randomized, controlled, clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19421678" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Therapeutic role of oral water soluble iodinated contrast agent in postoperative small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8165534" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Therapeutic effect of oral Gastrografin in adhesive, partial small-bowel obstruction: a prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15968731" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12131078" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Therapeutic value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16076330" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Randomized controlled trial of Gastrografin in adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16319052" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Comparison of Urografin versus standard therapy in postoperative small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17636770" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Oral water soluble contrast for the management of adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20205228" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Systematic review and meta-analysis of the diagnostic and therapeutic role of water-soluble contrast agent in adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19524265" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Clinical impacts of oral gastrografin follow-through in adhesive small bowel obstruction (SBO).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31205220" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Outcomes of a low-osmolar water-soluble contrast pathway in small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17380561" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Meta-analysis of oral water-soluble contrast agent in the management of adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26329902" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Water-soluble contrast agent in adhesive small bowel obstruction: a systematic review and meta-analysis of diagnostic and therapeutic value.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21227018" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Hyperosmolar water-soluble contrast medium in the management of adhesive small-intestine obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9876076" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Water-soluble contrast study predicts the need for early surgery in adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30502278" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A Significant Proportion of Small Bowel Obstructions Require&gt;48 Hours to Resolve After Gastrografin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7209787" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Small bowel obstruction: the role of nonoperative treatment in simple intestinal obstruction and predictive criteria for strangulation obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3690244" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Current spectrum of intestinal obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3296252" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Small intestinal obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7362010" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Mechanical bowel obstruction. Review of 316 cases in Benin City.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11816742" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : [Causes of intestinal obstruction].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11813483" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : [Mechanical intestinal obstruction caused by abdominal wall hernias].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15116825" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The epidemiology and treatment patterns of postoperative adhesion induced intestinal obstruction in Varsinais-Suomi Hospital District.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16989379" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Adhesive intestinal obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1935397" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : [Results of surgical treatment of mechanical ileus of the small intestine].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8216061" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : The operative aetiology and types of adhesions causing small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23522439" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Serum procalcitonin for predicting the failure of conservative management and the need for bowel resection in patients with small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20869092" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Predictive value of procalcitonin for bowel ischemia and necrosis in bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12397739" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The value of contrast radiology for postoperative adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24854302" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Trials of nonoperative management exceeding 3 days are associated with increased morbidity in patients undergoing surgery for uncomplicated adhesive small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23271094" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : How many sunsets? Timing of surgery in adhesive small bowel obstruction: a study of the Nationwide Inpatient Sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26243347" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : "Right place at the right time" impacts outcomes for acute intestinal obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29170020" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Impact of Race on the Surgical Management of Adhesive Small Bowel Obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31062274" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Longer Trials of Non-operative Management for Adhesive Small Bowel Obstruction Are Associated with Increased Complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21255429" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Bologna Guidelines for Diagnosis and Management of Adhesive Small Bowel Obstruction (ASBO): 2010 Evidence-Based Guidelines of the World Society of Emergency Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22472395" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Factors predicting need for and delay in surgery in small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20632281" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Clinicoradiological score for predicting the risk of strangulated small bowel obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26307871" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : A multi-institution prospective observational study of small bowel obstruction: Clinical and computerized tomography predictors of which patients may require early surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23497503" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Tuberculous bowel obstruction at a university teaching hospital in Northwestern Tanzania: a surgical experience with 118 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3484844" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Surgical management of radiation enteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6870521" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Surgical management of small-bowel radiation enteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24649301" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Malignant bowel obstruction: A retrospective clinical analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24477929" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3279551" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Obstruction of the large and small intestine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1727026" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Small bowel obstruction in patients with a prior history of cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3729182" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Intestinal obstruction in cancer patients. An assessment of risk factors and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8435356" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Management of bowel obstruction in advanced and terminal cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15922204" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Advanced abdominal imaging is not required to exclude strangulation if complete small bowel obstructions undergo prompt laparotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31452077" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Parenteral Nutrition Instead of Early Reoperation in the Management of Early Postoperative Small Bowel Obstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26446450" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : A Double-Blinded Randomized Clinical Study on the Therapeutic Effect of Gastrografin in Prolonged Postoperative Ileus After Elective Colorectal Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25575258" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Gastrografin in Prolonged Postoperative Ileus: A Double-blinded Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2301905" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Intestinal obstruction from adhesions--how big is the problem?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4580750" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Peritoneal adhesions and their relation to abdominal surgery. A postmortem study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34217331" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Diagnosis and management of small bowel obstruction in virgin abdomen: a WSES position paper.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27780001" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Small Bowel Obstructions in a Virgin Abdomen: Is an Operation Mandatory?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24565365" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Small bowel obstruction in the virgin abdomen: the need for a mandatory laparotomy explored.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27561369" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Small bowel obstruction in the virgin abdomen: time to challenge surgical dogma with evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30885455" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Small bowel obstruction in a virgin abdomen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30505438" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Band adhesions not related to previous abdominal surgery - A retrospective cohort analysis of risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28785841" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Clinical Effect of Water-Soluble Contrast Agents for Small Bowel Obstruction in the Virgin Abdomen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19756860" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Adhesional small bowel obstruction in the absence of previous operations: management and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29965940" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Deconstructing dogma: Nonoperative management of small bowel obstruction in the virgin abdomen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32574687" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Safety of Foregoing Operation for Small Bowel Obstruction in the Virgin Abdomen: Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16905885" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Acute abdominal pain among elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25421079" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Management and outcomes of small bowel obstruction in older adult patients: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30377439" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Small bowel obstruction in the elderly: a plea for comprehensive acute geriatric care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30242455" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Allograft tendons are a safe and effective option for revision ACL reconstruction: a clinical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24380988" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Causes of small bowel obstruction after Roux-en-Y gastric bypass: a review of 2,395 cases at a single institution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19478629" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Small-bowel obstruction after laparoscopic Roux-en-Y gastric bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22796431" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Surgical management of early small bowel obstruction after laparoscopic Roux-en-Y gastric bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30489509" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Management of adhesive small bowel obstruction: A distinct paradigm shift in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30633102" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Outcomes in Adhesive Small Bowel Obstruction from a Large Statewide Database: What to Expect after Non-Operative Management.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
